Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults
Fig 3
Magnitude of ADCC responses using IMC-infected and gp120-coated targets.
The magnitude of the ADCC responses against subtype B (SF162) and CRF01_AE (CM235) targets using gp120-coated targets in the ADCC-GTL assay (A) or using IMC-infected targets in the ADCC-Luciferase assay (B) is shown. In both assays, the CRF01_AE ADCC response was the most potent.